Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS and SWE for Sarcoma Response Assessment
NCT02384473Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Dec 2014
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Southern California. Primary endpoint: Inter-reader agreement for sequential contrast-enhanced ultrasound up to 9 weeks. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02384473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02384473.